Clinical significance of androgen secretion disorders in men with a malignancy. (Q33840617)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

review article

2 references

17 August 2020

Clinical significance of androgen secretion disorders in men with a malignancy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

2 references

3 April 2019

17 August 2020

1 reference

17 November 2019

tumor of testis and paratestis

2 references

17 November 2019

17 August 2020

2 references

PubMed publication ID

17 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Tomasz Demkow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Grazyna M Poniatowska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Wojciech Michalski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Karol Nietupski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Joanna Rzymowska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

1 reference

1 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 July 2017

1 reference

17 August 2020

5 references

24 March 2019

3 April 2019

17 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

17 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

21 March 2020

4 references

24 March 2019

3 April 2019

17 November 2019

on focus list of Wikimedia project

17 August 2020

copyrighted

0 references

ScienceSource

0 references

cites work

Metabolic syndrome in patients with prostate cancer undergoing intermittent androgen-deprivation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Testosterone Therapy Among Prostate Cancer Survivors.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Impact of Androgen Deprivation Therapy on Sexual and Hormonal Function in Patients Receiving Radiation Therapy for Prostate Cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Clinical Predictors of Fatigue in Men With Non-Metastatic Prostate Cancer Receiving External Beam Radiation Therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

The Prevalence of Cardiac Risk Factors in Men with Localized Prostate Cancer Undergoing Androgen Deprivation Therapy in British Columbia, Canada

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Global incidence and outcome of testicular cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Clinical exercise interventions in prostate cancer patients--a systematic review of randomized controlled trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Androgen deprivation therapy and cardiovascular risk

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Onset of effects of testosterone treatment and time span until maximum effects are achieved

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

The efficacy and safety of testosterone undecanoate (Nebido(®)) in testosterone deficiency syndrome in Korean: a multicenter prospective study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Managing hot flushes in men after prostate cancer--a systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Impact of androgen deprivation therapy on cardiovascular disease and diabetes.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Management of complications of androgen deprivation therapy in the older man.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Oligozoospermia with normal fertility in male mice lacking the androgen receptor in testis peritubular myoid cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Presence of delta opioid receptors on a subset of hypothalamic gonadotropin releasing hormone (GnRH) neurons.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Thinking with your gonads: testosterone and cognition

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Androgen deprivation therapy for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Fertility, gonadal and sexual function in survivors of testicular cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

The decline of androgen levels in elderly men and its clinical and therapeutic implications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

The blood in systemic disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Endocrinological late effects after chemotherapy for testicular cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Plasma testosterone and luteinizing hormone levels during levo-alpha-acetylmethadol maintenance and withdrawal

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Long-term toxicity of chemotherapy for testicular cancer--the cost of cure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism

5 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Risk factors for post-treatment hypogonadism in testicular cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Androgen deficiency symptoms in testicular cancer survivors are associated with sexual problems but not with serum testosterone or therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

The quality of life and hormonal disturbances in testicular cancer survivors in Cisplatin era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Early development of the metabolic syndrome after chemotherapy for testicular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Changes in cerebral glucose metabolism and visuospatial capability in hypogonadal males under testosterone substitution therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Population-based study of cardiovascular mortality among patients with prostate cancer treated with radical external beam radiation therapy with and without adjuvant androgen deprivation therapy at the British Columbia Cancer Agency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Intermittent versus continuous androgen deprivation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Hypogonadism in male patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Adipokines in patients with cancer anorexia and cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-017-0982-6

Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486517

Testicular function following combination chemotherapy with Cis-platin, vinblastine, and bleomycin

29 October 2018

1 reference

12 December 2020

Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency

1 reference

12 December 2020

Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancer

1 reference

12 December 2020

Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist

1 reference

12 December 2020

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

1 reference

12 December 2020

A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy

1 reference

12 December 2020

The influence of testosterone suppression and recovery on sexual function in men with prostate cancer: observations from a prospective study in men undergoing intermittent androgen suppression

1 reference

12 December 2020

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality

1 reference

12 December 2020

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations

1 reference

12 December 2020

Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

12 December 2020

10.1007/S12032-017-0982-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

21 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

PubMed publication ID

28573637

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28573637%20AND%20SRC:MED&resulttype=core&format=json